BORYUNG PHARM revenue for the last year amounted to 859.60 B KRW, the most of which — 498.36 B KRW — came from its highest performing source at the moment, Manufactured Product, the year earlier bringing 446.10 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought BORYUNG PHARM 859.63 B KRW, and the year before that — 760.48 B KRW.